VBI VACCINES INC's ticker is VBIV and the CUSIP is 91822J103. A total of 132 filers reported holding VBI VACCINES INC in Q1 2022. The put-call ratio across all filers is 0.75 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $28,027 | -73.4% | 92,500 | -65.7% | 0.00% | – |
| Q4 2022 | $105,465 | -13.6% | 269,661 | +55.7% | 0.00% | – |
| Q3 2022 | $122,000 | -68.9% | 173,219 | -64.2% | 0.00% | – |
| Q2 2022 | $392,000 | -33.8% | 484,193 | +35.8% | 0.00% | – |
| Q1 2022 | $592,000 | -21.6% | 356,455 | +10.5% | 0.00% | – |
| Q4 2021 | $755,000 | -25.4% | 322,446 | -1.0% | 0.00% | – |
| Q3 2021 | $1,012,000 | -86.6% | 325,612 | -85.5% | 0.00% | -100.0% |
| Q2 2021 | $7,533,000 | +410.0% | 2,248,929 | +373.7% | 0.00% | – |
| Q1 2021 | $1,477,000 | +16.5% | 474,724 | +3.0% | 0.00% | – |
| Q4 2020 | $1,268,000 | +29.4% | 461,001 | +34.6% | 0.00% | – |
| Q3 2020 | $980,000 | -70.9% | 342,400 | -68.5% | 0.00% | -100.0% |
| Q2 2020 | $3,366,000 | +2932.4% | 1,085,906 | +827.4% | 0.00% | – |
| Q1 2020 | $111,000 | +91.4% | 117,088 | -5.5% | 0.00% | – |
| Q3 2019 | $58,000 | +87.1% | 123,932 | +366.3% | 0.00% | – |
| Q2 2019 | $31,000 | +10.7% | 26,576 | +49.6% | 0.00% | – |
| Q4 2018 | $28,000 | – | 17,768 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 55,042,465 | $171,182,000 | 2.49% |
| GENERAL AMERICAN INVESTORS CO INC | 1,877,497 | $5,839,000 | 0.50% |
| HighVista Strategies LLC | 41,271 | $129,000 | 0.08% |
| ArchPoint Investors | 65,000 | $202,000 | 0.06% |
| FIRST MIDWEST BANK TRUST DIVISION | 136,714 | $425,000 | 0.06% |
| FNY Investment Advisers, LLC | 24,683 | $76,000 | 0.04% |
| GRIMES & COMPANY, INC. | 257,960 | $802,000 | 0.04% |
| Cambridge Investment Research Advisors, Inc. | 2,065,953 | $6,425,000 | 0.03% |
| Ergoteles LLC | 171,127 | $532,000 | 0.02% |
| J.W. COLE ADVISORS, INC. | 71,100 | $221,000 | 0.02% |